Cargando…

Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency

CONTEXT: In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR). OBJECTIVE: We sought...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorin, Richard I., Qiao, Zhi George, Bouchonville, Matthew, Qualls, Clifford R., Schrader, Ronald M., Urban, Frank K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686692/
https://www.ncbi.nlm.nih.gov/pubmed/29264545
http://dx.doi.org/10.1210/js.2017-00198
Descripción
Sumario:CONTEXT: In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR). OBJECTIVE: We sought to characterize maximal cortisol secretion rate (CSR(max)) and free cortisol half-life in patients with SAI, compare results with those of age-matched healthy controls, and examine the influence of predictor variables on ACTH-stimulated cortisol concentrations. DESIGN: CSR(max) was estimated from ACTH(1-24) (250 μg)(–)stimulated cortisol time-concentration data. Estimates for CSR(max) and free cortisol half-life were obtained for both dexamethasone (DEX) and placebo pretreatment conditions for all subjects. SETTING: Single academic medical center. PATIENTS: Patients with SAI (n = 10) compared with age-matched healthy controls (n = 21). INTERVENTIONS: The order of DEX vs placebo pretreatment was randomized and double-blind. Cortisol concentrations were obtained at baseline and at intervals for 120 minutes after ACTH(1-24). MAIN OUTCOME MEASURES: CSR(max) and free cortisol half-life were obtained by numerical modeling analysis. Predictors of stimulated cortisol concentrations were evaluated using a multivariate model. RESULTS: CSR(max) was significantly (P < 0.001) reduced in patients with SAI compared with controls for both placebo (0.17 ± 0.09 vs 0.46 ± 0.14 nM/s) and DEX (0.18 ± 0.13 vs 0.43 ± 0.13 nM/s) conditions. Significant predictors of ACTH(1-24–)stimulated total cortisol concentrations included CSR(max), free cortisol half-life, and baseline total cortisol, corticosteroid-binding globulin, and albumin concentrations (all P < 0.05). CONCLUSIONS: Our finding of significantly decreased CSR(max) confirms that SAI is associated with alterations in the CSR-ACTH dose-response curve. Decreased CSR(max) contributes importantly to the laboratory diagnosis of SAI.